Group 1: Financial Performance - The company achieved an operating income of 1,723,163.39 million yuan in 2024, a slight decline of 1.71% year-on-year, while the main business income grew by 3.27% to 1,714,818.82 million yuan [4] - The new material products developed by the company generated a revenue of 392.31 million yuan, marking a 68.19% increase year-on-year, with a net profit of 8.42 million yuan, up 125.23% [1] - The company's net profit for 2024 saw a significant decline of 168.72% due to increased competition and a 30% drop in average processing fees in the industry [8] Group 2: Market Strategy and Development - The company aims to optimize its industrial chain, expand overseas markets, and drive innovation as its three main growth themes [3] - The company plans to enhance its overseas market presence by establishing subsidiaries and warehouses in key markets [5] - The company is focused on becoming a global leader in PET bottle materials, with ongoing capacity expansion and product development plans [21] Group 3: Investor Relations and Market Perception - The company has implemented measures such as employee stock ownership plans, share buyback plans, and major shareholder increase plans to boost market confidence [6] - The stock price has significantly declined since the IPO, attributed to various market factors, but the company is committed to improving performance to support stock price recovery [22] - The company has received inquiries regarding the potential for stock sales by major shareholders upon the expiration of lock-up periods, with no current plans for such actions [18] Group 4: Research and Development - The company invested 60.42 million yuan in R&D in 2024, focusing on breakthroughs in PETG, bio-based polyester, and other new materials [16] - The company is exploring collaborations in the humanoid robot sector, with potential applications for its polyester products [15] Group 5: Risk Management - The company faces significant exposure to foreign exchange fluctuations due to its substantial overseas sales, and it employs hedging strategies to mitigate these risks [13] - The company has established strict management protocols for its risk management strategies, particularly concerning raw material futures and foreign exchange hedging [32]

万凯新材表示，灵心巧手是一家以"灵巧手+云端智脑"为核心的人形机器人具身智能平台。公司本次投 资主要是基于看好人形机器人赛道所作的前瞻性布局，后续公司计划依托区域优势和上市公司影响力， 充分发挥资源整合作用，深入参与并助力灵心巧手在杭州或周边落地新产能，为其赋能当地有协同性的 优质社会资源，助力其在机器人产业聚集地深耕发展。同时，拟与灵心巧手共同研发和探索公司聚酯新 材料产品在人形机器人领域应用的可能性，与公司主业形成一定的产业协同。 一季报显示，万凯新材长期股权投资约7533万元，同比增长近200%，主要系增加对灵心巧手的投资。 今年4月21日，投资者在深交所互动平台上提问公司是否参投灵心巧手，公司回复近期作为领投人之一 参与了灵心巧手(北京)科技有限公司的PRE-A轮融资，投后股权占比8.2%，并拥有一名董事席位。目前 公司占比较小，后续产业合作亦仅作为计划，具有不确定性，对公司2025年经营业绩不会构成重大影 响。 公告显示，万凯新材料股份有限公司是国内领先的聚酯材料研发、生产、销售企业，致力于为社会提供 健康、安全、环保、优质的聚酯材料，已建成年产300万吨瓶级切片的产能。公司产能规模居全球前 列，是 ...

特此公告。 万凯新材料股份有限公司 2025 年第一季度报告披露提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 万凯新材料股份有限公司（以下简称"公司"）于2025年4月28日召开第二 届董事会第二十二次会议和第二届监事会第十九次会议，审议通过了《公司 2025年第一季度报告》。 为使投资者全面了解公司的经营成果、财务状况等相关情况，公司《2025 年第一季度报告》已于2025年4月29日在中国证监会指定的创业板信息披露网站 巨潮资讯网（www.cninfo.com.cn）上披露，敬请投资者注意查阅。 | 证券代码：301216 | 证券简称：万凯新材 公告编号：2025-033 | | --- | --- | | 债券代码：123247 | 债券简称：万凯转债 | 万凯新材料股份有限公司董事会 2024 年 4 月 29 日 1 ...

| 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 上海拓牌私募基金管理有限公司-拓牌兴丰6号私募证券投资 基金 | 2498.49 | 8.77 | -76.97 | | 深圳盈富汇智私募证券基金有限公司-盈富增信添利23号私 募证券投资基金 | 1726.06 | 6.06 | 不变 | | 广州复朴道和投资管理有限公司-衢州复朴长实投资合伙企 业(有限合伙) | 1533.77 | 5.38 | -11.00 | | 宁波长江奇湾股权投资基金管理有限公司-宁波长江奇湾股 | | | | | 权投资基金合伙企业(有限合伙) | 1335.03 | 4.69 | 不变 | | 中烨正企(北京)国际投资有限公司-中烨悦川1号私募证券投 资基金 | 719.91 | 2.53 | 新进 | | 摩根新兴动力混合A类 | 452.95 | 1.59 | 新进 | | 中烨正企(北京)国际投资有限公司-中烨金盈1号私募证券投 资基金 | 406.48 | 1.43 | 新进 | | 中烨正企(北京)国际投资 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥3,919,002,132.55, a decrease of 7.74% compared to ¥4,247,946,950.07 in the same period last year[5]. - Net profit attributable to shareholders increased by 5.92% to ¥47,964,535.74 from ¥45,281,863.09 year-on-year[5]. - The company reported a basic earnings per share of ¥0.09, unchanged from the previous year, while diluted earnings per share decreased by 22.22% to ¥0.07[5]. - The total operating revenue for the current period is CNY 3,919,002,132.55, a decrease of approximately 7.75% compared to CNY 4,247,946,950.07 in the previous period[25]. - The total profit for the current period is 42,669,056.81, down from 62,334,523.46 in the previous period, indicating a decrease of about 31.5%[26]. - The operating profit for the current period is 43,502,303.40, compared to 61,447,081.98 in the previous period, showing a decline of approximately 29.2%[26]. - The total comprehensive income for the current period is 48,502,440.04, compared to 45,351,523.88 in the previous period, reflecting an increase of approximately 4.8%[27]. Cash Flow - The net cash flow from operating activities improved significantly, reaching ¥236,152,729.88, a 245.19% increase from a negative cash flow of ¥162,653,192.17 in the previous year[5]. - Operating cash flow for Q1 2025 was ¥236,152,729.88, a significant increase of 245.19% compared to a cash outflow of ¥162,653,192.17 in Q1 2024, primarily due to a reduction in inventory[12]. - The cash flow from operating activities for the current period is 236,152,729.88, a significant improvement from -162,653,192.17 in the previous period[29]. - The cash flow from investing activities shows a net outflow of -194,042,406.12, compared to -409,202,342.61 in the previous period, indicating a reduction in cash outflow[31]. - The cash flow from financing activities resulted in a net outflow of -50,406,618.13, contrasting with a net inflow of 658,706,177.08 in the previous period[31]. - The company received cash from operating activities totaling 4,688,855,716.64, down from 5,789,696,301.89 in the previous period, indicating a decrease of approximately 18.9%[29]. Assets and Liabilities - Total assets at the end of the reporting period were ¥17,490,049,113.36, down 1.60% from ¥17,775,030,802.32 at the end of the previous year[5]. - The total liabilities decreased to CNY 12,105,758,355.20 from CNY 12,437,817,073.90, reflecting a reduction of about 2.67%[24]. - The company's equity attributable to shareholders increased to CNY 5,384,173,197.37 from CNY 5,338,979,319.95, an increase of approximately 0.84%[25]. - The company's cash and cash equivalents at the end of the period are CNY 3,065,334,419.82, slightly up from CNY 3,063,843,810.72 at the beginning of the period[21]. - Accounts receivable increased to CNY 800,253,118.80 from CNY 698,726,721.04, representing a growth of approximately 14.56%[22]. - Inventory decreased to CNY 3,366,003,592.25 from CNY 3,691,105,608.79, indicating a decline of about 8.80%[22]. - The total assets of the company as of March 31, 2025, are CNY 17,490,049,113.36, down from CNY 17,775,030,802.32, a decrease of approximately 1.61%[24]. - The company has reduced its trading financial assets to CNY 392,370,273.22 from CNY 520,766,243.15, a decrease of about 24.61%[21]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 27,411, with no preferred shareholders having restored voting rights[14]. - Zhejiang Zhengkai Group Co., Ltd. holds 36.41% of shares, making it the largest shareholder, followed by Shen Zhigang with 6.57%[14]. - The top ten shareholders collectively hold significant stakes, with the largest being 187,586,542 shares held by Zhejiang Zhengkai Group Co., Ltd.[14]. - The company repurchased 4,595,345 shares, representing 0.89% of the total share capital, ranking it as the 9th largest shareholder[15]. - All major shareholders are subject to lock-up agreements until September 29, 2025, with no shares being released during the reporting period[18]. - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending activities[16]. Expenses and Investments - Management expenses increased by 30.40% to ¥43,241,944.13 due to increased personnel costs from new companies[11]. - Financial expenses surged by 249.73% to ¥10,219,619.13, influenced by exchange gains and convertible bond financing costs[11]. - Investment income dropped by 83.68% to ¥3,260,418.19, impacted by futures trading and financial management activities[11]. - Investment cash flow for Q1 2025 was -¥194,042,406.12, a decrease of 52.58% from -¥409,202,342.61 in Q1 2024, mainly due to reduced expenditures on fixed assets[12]. - The controlling shareholder plans to increase their stake in the company by investing between CNY 100 million and CNY 200 million within six months[19].

万凯新材（301216.SZ）发布2024年年报显示，公司以"产业链优化、海外拓展、研发创新"三大战略方 向，以高质量发展应对行业周期挑战。 核心业务仍保持增长韧性 2024年，公司全年实现营业收入172.32亿元，同比小幅下滑1.71%，但若剔除其他业务收入影响，其核 心主营业务收入达171.48亿元，同比增长3.27%，表明公司核心业务仍保持增长韧性。 然而，受行业供需失衡、原材料价格波动及市场竞争加剧等因素影响，公司净利润出现亏损，归属于母 公司净利润为-3.00亿元，扣非净利润-2.14亿元，较2023年由盈转亏。这一业绩表现与国内聚酯瓶片行 业整体承压的趋势相符。 东方证券认为，目前瓶片行业扩张已进入尾声，公司通过向上游延伸产业链、加大海外业务布局来积极 应对行业周期，有望率先走出盈利底部。 2024年，国内聚酯瓶片行业仍处于产能集中投放期。据行业统计机构CCF数据，2024年国内新增聚酯瓶 片产能417万吨，总产能从2023年末的1661万吨增长至2043万吨，同比增幅高达28%。与此同时，2024 年国内聚酯瓶片产量约1556万吨，同比增长18.8%，产能增速远超需求增长，导致行业竞争加剧，产品 ...

值得一提的是研发方面，报告期内，万凯新材重点研发项目取得了阶段性进展，其中， "生物基呋喃聚酯项目" 持续推进与上下游合作资源协同推进研发 工作，已开展多次中试 ； "PET化学法再生技术项目" 已成功建设年产100吨级实验室中试线一套，用于展开不同等级废弃PET资源的再生试验研究； "新 型耐热共聚酯项目" 完成基础开发工作，推出了多个牌号高性能耐热聚酯工程塑料，已开始实现小批量销售。 此前，万凯新材就表示， 生物基呋喃聚酯（PEF）项目 是公司目前重点研发项目之一 ，主要应用在高阻隔包装材料上，可以满足 功能饮料、乳制品、 啤酒、药品包装等高阻隔包装应用 产品需求，市场前景良好。 声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文由作者重新编写，仅作新材料相关领域介绍，本文不构成任何投资建议！转载请注明来源！ 4月21日， 万凯新材 （301216） 发布2024年年度报告，2024年度，公司实现 营业收入172.32亿元，同比减少1.71% ；净亏损约3.00亿元，上年同 期则盈利4.37亿元；扣非净亏损2.14亿元，上年同期则盈利2.75亿元，基本每股亏损0.58元。 | | 2 ...

| 证券代码：301216 | 证券简称：万凯新材 | 公告编号：2025-032 | | --- | --- | --- | | 债券代码：123247 | 债券简称：万凯转债 | | 万凯新材料股份有限公司 关于举行 2024 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 万凯新材料股份有限公司董事会 万凯新材料股份有限公司（以下简称"公司"）《2024 年年度报告》已于 2025 年 4 月 21 日披露，为使投资者进一步了解公司的财务状况、经营情况及公 司发展规划，公司将于 2025 年 4 月 29 日（星期二）下午 15:00-16:00 在全景网 举行万凯新材 2024 年度网上业绩说明会，本次说明会将采用网络远程方式举行， 投资者可登陆 全景网"投资者关系互动平台"（http://ir.p5w.net）参与本次 业绩说明会。 2025 年 4 月 22 日 出席本次业绩说明会的人员有：公司董事长沈志刚先生、财务总监兼董事会 秘书高强先生、独立董事章击舟先生、保荐人代表李鹏飞先生。 为充分尊重投资者，提升交流的针对性， ...

证券代码：301216 证券简称：万凯新材 公告编号：2025-018 债券代码：123247 债券简称：万凯转债 一、重要提示 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者 应当到证监会指定媒体仔细阅读年度报告全文。 公司经本次董事会审议通过的利润分配预案为：以实施2024年度利润分配方案时股权登记日剔除回购股 份后的总股本为基数，向全体股东每10股派发现金红利1.5元（含税），送红股0股（含税），以资本公 积金向全体股东每10股转增0股。 所有董事均已出席了审议本报告的董事会会议。 中汇会计师事务所（特殊普通合伙）对本年度公司财务报告的审计意见为：标准的无保留意见。 本报告期会计师事务所变更情况：公司本年度会计师事务所由变更为中汇会计师事务所（特殊普通合 伙）。 非标准审计意见提示 □适用 √不适用 公司上市时未盈利且目前未实现盈利 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 √适用 □不适用 董事会决议通过的本报告期优先股利润分配预案 □适用 □不适用 2、报告期主要业务或产品简介 万凯新材料股份有限公司是国内领先的聚酯材料研发、生 ...

万凯新材：拟20.19亿元在印尼投建海外聚酯瓶片生产基地 金十数据4月20日讯，万凯新材公告称，公司计划通过全资子公司重庆万凯在印度尼西亚投资建设年产 75万吨的食品级PET新材料项目，总投资额为20.19亿元人民币。该项目旨在顺应行业发展趋势，符合 国家"一带一路"战略，并利用印尼市场的巨大潜力和独特的贸易优势。项目建设期为24个月，资金来源 为自有资金和自筹资金。公司表示，这将有助于提升其国际市场份额和品牌影响力。然而，项目需经过 中国国家相关部门及印尼相关部门的审批，存在一定的不确定性。 ...